These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3575364)

  • 1. Influence of atropine and N-methyl atropine pretreatments on behavioral and physiological effects of the irreversible muscarinic agonist, BM123.
    Overstreet DH; Russell RW; Booth RA; Jenden DJ
    Pharmacol Biochem Behav; 1987 Mar; 26(3):475-81. PubMed ID: 3575364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an irreversible muscarinic agonist (BM123) on avoidance and spontaneous alternation performance.
    Overstreet DH; Booth RA; Jenden DJ
    Pharmacol Biochem Behav; 1988 Oct; 31(2):337-43. PubMed ID: 3244711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid induction of supersensitivity to muscarinic antagonists-induced motor excitation by continuous stimulation of cholinergic receptors.
    Fernando JC; Hoskins B; Ho IK
    Life Sci; 1985 Sep; 37(9):883-92. PubMed ID: 4041002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and physiological effects associated with changes in muscarinic receptors following administration of an irreversible cholinergic agonist (BM 123).
    Russell RW; Smith CA; Booth RA; Jenden DJ; Waite JJ
    Psychopharmacology (Berl); 1986; 90(3):308-15. PubMed ID: 3097716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of selective central muscarinic blockade on schedule-controlled behavior and on the rate-decreasing effects of physostigmine.
    Hymowitz N; Brezenoff HE
    Pharmacol Biochem Behav; 1984 Jul; 21(1):109-15. PubMed ID: 6463084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventilatory effects of low-dose paraoxon result from central muscarinic effects.
    Houze P; Pronzola L; Kayouka M; Villa A; Debray M; Baud FJ
    Toxicol Appl Pharmacol; 2008 Dec; 233(2):186-92. PubMed ID: 18775447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II-induced hypothermia in rats.
    Wilson KM; Fregly MJ
    J Appl Physiol (1985); 1985 Feb; 58(2):534-43. PubMed ID: 3884574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic receptor blockade produces impairments in a sensorimotor subsystem for place navigation in the rat: evidence from sensory, motor, and acquisition tests in a swimming pool.
    Whishaw IQ; Tomie JA
    Behav Neurosci; 1987 Oct; 101(5):603-16. PubMed ID: 3675838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of cholinergic receptors in rat barrel cortex prevents long-term changes in the evoked potential during sensory preconditioning.
    Maalouf M; Miasnikov AA; Dykes RW
    J Neurophysiol; 1998 Aug; 80(2):529-45. PubMed ID: 9705448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation into atropine-induced antinociception.
    Ghelardini C; Malmberg-Aiello P; Giotti A; Malcangio M; Bartolini A
    Br J Pharmacol; 1990 Sep; 101(1):49-54. PubMed ID: 2282466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected synergism between an alkylating analog of oxotremorine and soman.
    Jenden DJ; Overstreet DH; Booth RA; Russell RW; Rice KM
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S78-83. PubMed ID: 4092897
    [No Abstract]   [Full Text] [Related]  

  • 12. Actions of cholinergic agonist and antagonists on the adrenocortical response of basal, hypoxic, and hypercapnic rats.
    Marotta SF; Sithichoke N
    Aviat Space Environ Med; 1977 May; 48(5):446-50. PubMed ID: 195569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of muscarinic receptor agonists and antagonists on alpha 2-adrenoceptors in rat brain.
    Hollingsworth PJ; Smith CB
    Eur J Pharmacol; 1989 Sep; 168(2):159-67. PubMed ID: 2558024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic receptor binding and behavioral effects of atropoine following chronic catecholamine depletion or acetylcholinesterase inhibition in rats.
    Schallert T; Overstreet DH; Yamamura HI
    Pharmacol Biochem Behav; 1980 Aug; 13(2):187-92. PubMed ID: 7413689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The suppression of behaviour in rats by previous experience and electric shock and its antagonism by atropine.
    Phillips KC; Lowe G
    Psychopharmacologia; 1975 Apr; 42(1):99-103. PubMed ID: 1153627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist regulation of muscarinic acetylcholine receptors in rat spinal cord.
    Taylor JE; Yaksh TL; Richelson E
    J Neurochem; 1982 Aug; 39(2):521-4. PubMed ID: 7086433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of posttraining administration of glucose on retention of a habituation response in mice: participation of a central cholinergic mechanism.
    Kopf SR; Baratti CM
    Neurobiol Learn Mem; 1996 May; 65(3):253-60. PubMed ID: 8616589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-related facilitation and suppression of drinking by muscarinic anticholinergic drugs in water non-deprived rats.
    Kuribara H; Tadokoro S
    Jpn J Pharmacol; 1988 Oct; 48(2):195-201. PubMed ID: 3210445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells.
    Fukamauchi F; Saunders PA; Hough C; Chuang DM
    Mol Pharmacol; 1993 Nov; 44(5):940-9. PubMed ID: 8246917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive effects of the novel spirocyclopiperazinium salt compound LXM-10 in mice.
    Yue CQ; Ye J; Li CL; Li RT; Sun Q
    Pharmacol Biochem Behav; 2007 Apr; 86(4):643-50. PubMed ID: 17379285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.